ABSTRACT

Objective:

Crimean-Congo hemorrhagic fever (CCHF) is the most common tick-borne viral hemorrhagic fever in our country and the world. While investigating the etiology of fever, tick contact should be questioned, especially in rural areas, and CCHF should be remembered. This study aimed to review the characteristics of the cases detected in Bayburt, one of the cities where CCHF is endemic.

Methods:

A total of 100 patients aged 16 years and older who were diagnosed with CCHF in our clinic between April 2020 and October 2022 were included in the study. Demographic, epidemiological, and clinical characteristics, treatments, and prognoses of the patients were reviewed retrospectively through the hospital automation system and CCHF information system of The Ministry of Health.

Results:

Sixty one (61%) of the patients included in the study were male, and their primary age (± standard deviation) was 50.4±15.7. 77% of the patients engaged in farming and or animal husbandry, and 71% were living in rural areas. The highest number of cases was in June and July. 63% of the patients had a history of a tick bite. At the first presentation, there were complaints of fatigue (95%), generalized body pain (84%), headache (67%), and fever (65%), in order of frequency. Ribavirin was started in 52 (52%) patients. One patient admitted in the late period died, and 99 patients were discharged with good recovery.

Conclusion:

CCHF is an important public health problem that has been causing seasonal epidemics in our country for nearly two decades. Although sporadic cases have been reported from almost every region, the disease is endemic in some areas. Since signs and symptoms are not specific, the disease can be easily missed when tick contact is not questioned. Therefore CCHF should be considered in patients presenting with fever and thrombocytopenia in rural areas, especially in the spring and summer months.

Keywords: Crimean-congo hemorrhagic fever, epidemiology, tick bite

References

Adams MJ, Lefkowitz EJ, King AMQ, Harrach B, Harrison RL, Knowles NJ, et al. Changes to taxonomy and the International Code of Virus Classification and Nomenclature ratified by the International Committee on Taxonomy of Viruses (2017). Arch Virol 2017; 162: 2505-38.

Ergönül O. Crimean-Congo haemorrhagic fever. Lancet Infect Dis 2006; 6: 203-14.

Engin A. Crimean-Congo Hemorrhagic Fever: Characteristics of Virus and Epidemiology. Inf Dis Special Topics 2014; 7: 9-1320.

Tülek N. Crimean-Congo Hemorrhagic Fever. Turkiye Klinikleri J Inf Dis Special Topics 2014; 7: 19-28.

Erbay A. Crimean-Congo Hemorrhagic Fever Virus in ‘Manual of Security Sensitive Microbes and Toxins. Florida: CRC Press 2014: 37-52.

Yilmaz GR, Buzgan T, Irmak H, Safran A, Uzun R, Cevik MA, et al. The epidemiology of Crimean-Congo hemorrhagic fever in Turkey, 2002–2007. International Journal of Infectious Diseases 2009; 13: 380-6.

Gozalan A, Esen B, Fitzner J, Sua Tapar F, Peker Ozkan A, Georges-Courbot M-C, et al. Crimean-Congo haemorrhagic fever cases in Turkey. Scandinavian Journal of Infectious Diseases 2007; 39: 332-6.

Zoonotik ve Vektörel Hastalıkları Dairesi Başkanlığı.Kırım-Kongo Kanamalı Ateşi (KKKA) Ankara: Sağlık Bakanlığı Halk Sağlığı Genel Müdürlüğü (erişim 21 Ocak 2023): https://hsgm.saglik.gov.tr/tr/zoonotikvektorel-kkka.

Çiftçi E. Ülkemizde Yeni Ortaya Çıkan Bir Enfeksiyon Hastalığı: Kırım Kongo Kanamalı Ateşi. Journal of Pediatric Infection/Cocuk Enfeksiyon Dergisi. 2009;3.

Çevik MA, Erbay A, Bodur H, Gülderen E, Baştuğ A, Kubar A, et al. Clinical and laboratory features of Crimean-Congo hemorrhagic fever: predictors of fatality. IJID 2008; 12: 374-9.

Uyar Y, Çarhan A. Kırım Kongo Kanamalı Ateşi’nin Ülkemizdeki Epidemiyolojisi. 2009.

Tartar AS, Balın ŞÖ, Akbulut A, Demirdağ K. Türkiye’nin Doğusunda Kırım Kongo Kanamalı Ateşi: Epidemiyolojik ve Klinik Değerlendirme. 2018.

Öngürü PBH. Kırım Kongo kanamalı ateşi. J Exp Clin Med 2012; 29: 175-8.

Alkan-Çeviker S, Günal Ö, Kılıç SS. Retrospective Analysis of Crimean-Congo Haemorrhagic Fever Cases. Klimik Dergisi 2019; 32: 275-80.

Akyol D, Erdem Kıvrak E, Erdem HA, Pullukçu H, Sipahi OR, Tasbakan M. Kırım-Kongo kanamalı ateşi:16 olgunun klinik özelliklerinin ve laboratuvar bulgularının değerlendirilmesi Flora 2020; 25: 544-8.

LeDuc JW. Epidemiology of hemorrhagic fever viruses. Reviews of infectious diseases. 1989;11(Supplement_4):S730-S5.

Elaldi N, Kaya S. Crimean-Congo hemorrhagic fever. J Microbil Infect Dis 2014; 4: 1-9.

Baran Aİ, Çelik M, Arslan Y, Menteş O, Sünnetçioğlu M. Kırım-Kongo Kanamalı Ateşi: 10 Olgunun Değerlendirilmesi. Harran Üniversitesi Tıp Fakültesi Dergisi 2021; 18: 464-7.

Aker S, Akıncı H, Kılıçoğlu C, Leblebicioglu H. The geographic distribution of cases of Crimean-Congo hemorrhagic fever: Kastamonu, Turkey. Ticks and Tick-borne Dis 2015; 6: 730-6.

Zıvalıoğlu M. Kırım-Kongo ateşi hastalığının epidemiyolojik özelliklerinin belirlenmesi. 2008.

T.C. Çevre, Şehircilik ve İklim Değişikliği Bakanlığı. Bayburt’un Coğrafi Yapısı, (erişim 27 Şubat 2023) https://bayburt.csb.gov.tr/cografi-yapisi-i-2616.

Ozkurt Z, Kiki I, Erol S, Erdem F, Yılmaz N, Parlak M, et al. Crimean–Congo hemorrhagic fever in Eastern Turkey: clinical features, risk factors and efficacy of ribavirin therapy. J Infect 2006; 52: 207-15.

Parlak E, Ertürk A, Koşan Z, Parlak M, Özkurt Z. A nosocomial outbreak of Crimean-Congo hemorrhagic fever. Journal of Microbiology and Infectious Diseases 2015; 5: 5-9.

Bakir M, Ugurlu M, Dokuzoguz B, Bodur H, Tasyaran MA, Vahaboglu H, et al. Crimean-Congo haemorrhagic fever outbreak in Middle Anatolia: a multicentre study of clinical features and outcome measures. J Med Microbiol 2005; 54: 385-9.

Karti SS, Odabasi Z, Korten V, Yilmaz M, Sonmez M, Caylan R, et al. Crimean-Congo hemorrhagic fever in Turkey. Emerg Infect Dis 2004; 10: 1379-84.

Aslam S, Latif MS, Daud M, Rahman ZU, Tabassum B, Riaz MS, et al. Crimean‑Congo hemorrhagic fever: Risk factors and control measures for the infection abatement. Biom Rep 2016; 4: 15-20.

Yapıcı K, Demir C, Karahocagil MK, Uluç HH, Ceylan A, Akdeniz H. Crimean-Congo Hemorrhagic Fever: Evaluation of 12 Cases. Van Tıp Derg 2010; 17: 46-9.

Ergönül Ö, Celikbaş A, Dokuzoğuz B, Eren Ş, Baykam N, Esener H. Characteristics of patients with Crimean-Congo hemorrhagic fever in a recent outbreak in Turkey and impact of oral ribavirin therapy. Clin Infect Dis 2004; 39: 284-7.

Coleman JJ, Manavi K, Marson EJ, Botkai AH, Sapey E. COVID-19: to be or not to be; that is the diagnostic question. Postgrad Med J 2020; 96: 392-8.

Pourbagheri-Sigaroodi A, Bashash D, Fateh F, Abolghasemi H. Laboratory findings in COVID-19 diagnosis and prognosis. Clin Chim Acta 2020; 510: 475-82.

Büyüktuna S, Hasbek M, Öksüz C, Baysal C, Öz M, Elaldını N, et al. COVID-19 Co-infection in a patient with Crimean Congo Hemorrhagic Fever: A Case Report. Mikrobiyol Bul 2021; 55: 445-51.

Tartar AS, Akbulut A, Demirdağ K, Balin Ş. Crimean-Congo Hemorrhagic Fever in Differential Diagnosis During the Coronavirus Disease-2019 Pandemic. Turkiye Parazitol Derg 2022; 46: 50-3.

Ergönül Ö. Crimean-Congo Haemorrhagic Fever: Treatment and Use of Ribavirin. Klimik Journal/Klimik Dergisi 2016; 29: 2-9.

Mardani M, Jahromi MK, Naieni KH, Zeinali M. The efficacy of oral ribavirin in the treatment of crimean-congo hemorrhagic fever in Iran. Clin Infect Dis 2003; 36: 1613-8.

Alavi-Naini R, Moghtaderi A, Koohpayeh HR, Sharifi-Mood B, Naderi M, Metanat M, et al. Crimean-Congo hemorrhagic fever in Southeast of Iran. J Infect 2006; 52: 378-82.

Elaldi N, Bodur H, Ascioglu S, Celikbas A, Ozkurt Z, Vahaboglu H, et al. Efficacy of oral ribavirin treatment in Crimean-Congo haemorrhagic fever: a quasi-experimental study from Turkey. J i-Infect 2009; 58: 238-44.

Kandis H, Katirci Y, Baltaci D, Saritas A, Kara IH, Geyik MF. Investigation of clinical and laboratory findings of 26 cases with Crimean-Congo hemorrhagic fever. Biomedical Research 2012; 23: 589-95.

Big Epidemic of Small City: Crimean-Congo Hemorrhagic Fever

ABSTRACT

References